2009 China Withdrew More Than 4,300 Drug Approvals
This article was originally published in PharmAsia News
Executive SummaryChina's State FDA Drug Registration Department Secretary Zhang Wei disclosed Feb. 25 that in 2009 the department conducted comprehensive inspections of 170,000 drug approvals, and revoked over 4,300
You may also be interested in...
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.